Skip to content

Search

Search managers or tickers

Brave Warrior Advisors

Q2 2014 13F · by Glenn Greenberg, portfolio manager

As of
Jun 30, 2014
Filed
Aug 14, 2014
US stock
$2.5B · prev $2.5B
Positions
13 · prev 12
Options notional
$0
Documents
1· no amendments

Picture100.0% US stock

Full picture · of what this 13F reports is US stock

  • US stock listed on a US exchange 100.0%
  • Foreign stock not listed in the US 0.0%
  • Notes debt, at principal 0.0%
  • Puts at notional value 0.0%
  • Calls at notional value 0.0%

Moves10 since the prior filing

The book

Very concentrated · behaves like 6 equal-sized positions

  1. Very concentrated
  2. Concentrated
  3. Focused
  4. Diversified

Moderate turnover · 51% a year, about 1.9 years per position

  1. Low
  2. Moderate
  3. High

Top 5 positions75% of US stock

  1. unresolved Valeant Pharmaceuticals Intl added+0.98 pp added+0.9830.8%
  2. unresolved Express Scripts Hldg Co added+2.32 pp added+2.3213.1%
  3. ORCL Oracle Corp added0.00 pp added0.0012.9%
  4. SCHW The Charles Schwab Corporation added+1.11 pp added+1.119.1%
  5. unresolved Kinder Morgan Management LLC trimmed−0.41 pp trimmed−0.419.0%

Positions13 in this filing · 0 exited

unresolvedValeant Pharmaceuticals Intl30.78%6,050,442$763Madded+8%+0.98 pp5 q
unresolvedExpress Scripts Hldg Co13.08%4,678,694$324Madded+32%+2.32 pp5 q
ORCLOracle Corp12.90%7,888,660$320Madded+1%0.00 pp5 q
SCHWThe Charles Schwab Corporation9.07%8,347,280$225Madded+16%+1.11 pp5 q
unresolvedKinder Morgan Management LLC9.03%2,837,047$224Mtrimmed−13%−0.41 pp3 q
MSFTMicrosoft Corp8.14%4,838,894$202Madded+21%+1.54 pp4 q
PRIPrimerica, Inc.6.48%3,357,924$161Mtrimmed−1%+0.05 pp5 q
unresolvedVistaprint N V5.92%3,630,690$147Madded+14%−0.40 pp5 q
unresolvedEquinix Inc4.32%509,260$107Mnew+4.32 ppnew
HALHalliburton Company0.20%70,777$5Mtrimmed−98%−9.50 pp5 q
unresolvedTidewater Inc0.04%19,625$1Mheld—3 q
CMCSAComcast Corp0.03%15,547$835,000held—3 q
BACBank of America Corporation0.01%14,532$223,000held—3 q

Source

Form
13F-HR
Reading
0 defects · 6 unresolved
Options
none in this filing
Notes
none in this filing
SEC cross-check
SEC data set not published yet